LND-Group, n(%) No LND-Group, n(%) P-value
Characteristics
Age (years), mean±standard deviation 60.3±9.8 63.4±10.8 <0.05
BMI (kg/m2), mean±standard deviation 28.3±7.8 31.7±8.1 <0.05
Additional Disease <0.05
Yes 90 (46.1) 38 (59.3)
No 105 (53.9) 26 (40.7)
Tumor size (cm) .73
>3 57 (29.2) 21 (32.8)
≤3 138 (70.8) 43 (67.2)
Risk Groups .13
Intermediate 108 (55.3) 33 (51.6)
High-intermediate 84 (44.7) 31 (48.4)
FIGO Stage .21
Stage IA 55 (28.2) 21 (32.8)
Stage IB 114 (58.5) 40 (62.6)
Stage II 6 (3.1) 3 (4.6)
Stage III 20 (10.3) NA
Grade .68
I–II (Low-grade) 153 (78.4) 49 (76.5)
III (High-grade) 42 (21.6) 15 (23.5)
LVSI .43
Yes 45 (23) 18 (28.1)
No 150 (77) 46 (71.9)
Adjuvant Treatment .22
None 89 (45.6) 28 (43.7)
Radiotherapy 101 (51.8) 33 (51.6)
Chemotherapy 2 (1.1) 1 (1.6)
Chemoradiotherapy 3 (1.5) 2 (3.1)
Recurrences (n) .77
No 183 (93.8) 59 (92.2)
Yes 12 (6.2) 5 (7.8)
NA: Not available, BMI: Body Mass Index NA: Not available, BMI: Body Mass Index NA: Not available, BMI: Body Mass Index NA: Not available, BMI: Body Mass Index